Health
Investigational Alzheimer’s drug reduces molecular markers of the disease – News-Medical.Net
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating…
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of…
Continue Reading
-
General15 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News19 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News19 hours agoWest End icon closes doors
-
General21 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay